Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2025.03.28
海普瑞：关于2024年度利润分配预案的公告
2025.03.28
海普瑞：独立董事2024年度述职报告-易铭
2025.03.28
海普瑞：独立董事2024年度述职报告-吕川
2025.03.28
海普瑞：独立董事2024年度述职报告-黄鹏
2025.03.28
海普瑞：董事会审计委员会对会计师事务所2024年度履行监督职责情况报告
2025.03.28
海普瑞：董事会决议公告
2025.03.28
海普瑞：董事会对独立董事独立性评估的专项意见
2025.03.28
海普瑞：第三期员工持股计划（修订稿）摘要
2025.03.28
海普瑞：第三期员工持股计划（修订稿）
2025.03.28
海普瑞：第二期员工持股计划（修订稿）摘要
第一页
上一页
1
2
3
4
5
下一页
最后一页
